Laser immunotherapy for advanced solid tumors
暂无分享,去创建一个
Feifan Zhou | Wei R. Chen | Mark F. Naylor | Tomas Hode | Xiaosong Li | Lu Alleruzzo | Joseph Raker | Siu Kit Lam | Wei R. Chen | M. Naylor | Xiaosong Li | T. Hode | Feifan Zhou | J. Raker | L. Alleruzzo
[1] Wei R. Chen,et al. Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine , 2013, Clinical & developmental immunology.
[2] Jedd D. Wolchok,et al. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations , 2016, Science Translational Medicine.
[3] Feifan Zhou,et al. Immunostimulatory properties of glycated chitosan. , 2011, Journal of X-ray science and technology.
[4] J. Vansteenkiste,et al. Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[5] J. Brennick,et al. Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. , 2003, Archives of dermatology.
[6] Robert E. Nordquist,et al. Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients , 2010, Cancer biology & therapy.
[7] Hong Liu,et al. Glycated chitosan as a new non-toxic immunological stimulant , 2009, Immunopharmacology and immunotoxicology.
[8] H. Kohrt,et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients , 2014, Nature.
[9] D. Schadendorf,et al. Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.
[10] R. Nordquist,et al. In situ photoimmunotherapy: a tumour‐directed treatment for melanoma , 2006, The British journal of dermatology.
[11] Hong Liu,et al. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. , 2002, Cancer research.
[12] R. Nordquist,et al. Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. , 1997, Cancer letters.
[13] M. Atkins,et al. Advances in immunotherapy for melanoma , 2016, BMC Medicine.
[14] R. Nordquist,et al. Antitumor immunity induced by laser immunotherapy and its adoptive transfer. , 2001, Cancer research.
[15] In situ photoimmunotherapy: a surgery- and limb-sparing approach to the treatment of cutaneous metastases in advanced melanoma. , 2010, Archives of dermatology.
[16] R. Emerson,et al. Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes , 2014, Oncoimmunology.
[17] N. Yawalkar,et al. Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients. , 2008, Archives of dermatology.
[18] V. Boussiotis. Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway. , 2016, The New England journal of medicine.
[19] D. Brizel,et al. Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[20] K. Schalper,et al. Basic Overview of Current Immunotherapy Approaches in Cancer. , 2016, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[21] P. Hegde,et al. The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition , 2016, Clinical Cancer Research.
[22] Wei R. Chen,et al. InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. , 2015, Cancer letters.
[23] I. Voutsadakis. Immune Blockade Inhibition in Breast Cancer. , 2016, Anticancer research.
[24] R. Emerson,et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.
[25] Hong Liu,et al. Enhancement of Laser Cancer Treatment by a Chitosan-derived Immunoadjuvant¶ , 2005, Photochemistry and photobiology.